MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 148 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $200,314 | -4.1% | 715 | -0.7% | 0.00% | 0.0% |
| Q4 2022 | $208,980 | +4.5% | 720 | -59.4% | 0.00% | -50.0% |
| Q4 2018 | $200,000 | -51.7% | 1,775 | -8.3% | 0.00% | -42.9% |
| Q3 2018 | $414,000 | -23.8% | 1,935 | -0.3% | 0.01% | -36.4% |
| Q2 2018 | $543,000 | +58.3% | 1,940 | -33.9% | 0.01% | +57.1% |
| Q1 2018 | $343,000 | -1.7% | 2,935 | -22.8% | 0.01% | 0.0% |
| Q4 2017 | $349,000 | +445.3% | 3,800 | -3.8% | 0.01% | +600.0% |
| Q2 2017 | $64,000 | -19.0% | 3,950 | -23.3% | 0.00% | -50.0% |
| Q1 2017 | $79,000 | +1028.6% | 5,150 | +930.0% | 0.00% | – |
| Q4 2016 | $7,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| University of Wisconsin Foundation | 73,487 | $17,003,422 | 28.29% |
| Tao Capital Management LP | 130,529 | $30,202 | 27.63% |
| Paulson & Co. | 1,105,741 | $255,846,353 | 23.09% |
| AlpInvest Partners B.V. | 211,488 | $48,934,093 | 11.18% |
| Bain Capital Life Sciences Investors, LLC | 324,619 | $75,110,344 | 7.20% |
| Avoro Capital Advisors LLC | 1,888,888 | $437,050,905 | 6.04% |
| Propel Bio Management, LLC | 30,032 | $6,948,804 | 5.76% |
| Baker Brothers Advisors | 1,969,798 | $455,771,861 | 5.19% |
| Rosalind Advisors, Inc. | 25,000 | $5,784,500 | 4.76% |
| TCG Crossover Management, LLC | 179,917 | $41,629,195 | 4.62% |